JLS
Venture capitalActively deployingNew York Β· 12 people tracked
Investment thesis
The firm operates at the intersection of precision neuromedicine, leveraging advances in neuroscience, technology, and data science. It targets companies that can translate scientific breakthroughs into therapeutic outcomes for patients while creating value for strategic acquirers in the healthcare and life sciences sectors.
Source: firm website, verified Jul 21, 2026.
Team Β· 12 people
from the firm's websiteWhat they invest in
from 1 of 18 portfolio companiesAI & Machine Learning Γ1Biotech Γ1Digital Health Γ1Healthtech Γ1
HQs:United StatesΓ1
Investments Β· 18 tracked
founders shown can be your intro pathGilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management. The company's pipeline spans depression, anxiety, addiction, and schizophrenia, with programs validated by AbbVie's acquisition of its first asset and partnerships with Columbia University and the National Institute on Drug Abuse.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
JONATHAN SPORN(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJonathan Sporn(Founder & CEO)
Frequently asked questions
- What sectors does JLS focus on?
- JLS focuses on Deep Tech, Digital Health, Medical Devices.
- Where is JLS located?
- JLS is headquartered in New York, US.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Karma Ventures is a venture capital firm investing in deep-tech software startups across Europe at late seed and Series A stages. The firm combines capital, time, and operational expertise to support founders building innovative technologies with early commercial traction and global market ambitions.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.